Piramal Enterprises' Diagnostic Division Launches QDx Instacheck

• First-of-its-kind revolutionary instant diagnostic device that tests 20 clinical parameters Right-here-Right-now
• Empowers doctors to take evidence based treatment decisions faster
• Reduces burden of high investments  in expensive devices while performing some critical tests

Piramal Enterprises’ diagnostic division recently announced the launch of “QDx Instacheck” Right-here-Right-now. It is a first-of-its-kind portable diagnostic device that is specifically designed to perform 20 clinical parameters and deliver quantitative results within 3 – 15 minutes. It covers wide therapeutic areas including cardiovascular disease, hormonal imbalance, emergency care, diabetes, oncology, infections, pregnancy and infertility management.

This portable and affordable device is unparalleled in delivering quantitative test results with lab accuracy. The device is virtually maintenance free and can be operated very easily with minimal training requirements. QDx Instacheck is particularly useful for doctors’ clinics, emergency care units (such as ICU, CCU), hospitals, pathological labs, IVF centres, ambulance services, pharmaceutical companies and NGOs engaged in healthcare services.

Commenting on the launch Mr. Vijay Shah, Executive Director and Chief Operating Officer, Piramal Enterprises Ltd. said, “It is our endeavour to empower the medical community such as gynaecologists, cardiologists, diabetologists, general physicians, pathological Labs etc to perform critical tests Right-here-Right-now with minimum investment and lowest operating expenses and finally making treatment decisions faster. The launch of QDx Instacheck is in line with our division’s vision of bringing affordable instant diagnostic solution through our point-of-care product range. This 1.3 kg portable device is the first-of-its-kind revolutionary instant diagnostic device in the Indian market that is poised to change traditional diagnostic methods to instant diagnosis.”

QDx Instacheck has been commercially test marketed from January to March 2013 across various parts of India through our field force and over 250 authorised distributors. The formal launch of the product is scheduled in April 2013. A record of 387 instruments was sold in just 45 days from test marketing launch!

About The Diagnostic Division
Piramal Enterprises entered the diagnostic business by acquiring Boehringer Mannheim India Ltd (Roche Diagnostics) in the year 1996. Currently the diagnostic division caters to both traditional Lab based diagnostic supplies and emerging point-of-care diagnostic market in physicians office. It primarily presents in Clinical Chemistry, Haematology, Immunology, Urine analysis and Rapid tests segments with leading brands like Diasys, Swelab etc. Diagnostic division’s future growth strategy is primarily build on emerging Point-of-Care segment with series of new launches of innovative instant diagnostic devices under in-house QDx brand in 2013.  

About Piramal Enterprises
Piramal Enterprises is one of India’s largest diversified companies, with a presence in pharmaceutical, financial services and information management sectors. Piramal Enterprises had consolidated revenues of $500M in FY2012. In the pharmaceutical space, PEL is one of leading custom manufacturing player globally, has presence in the global critical care segment with a portfolio of inhalation and injectible anesthetics and its OTC business is ranked no. 7 in India. PEL is also engaged in drug discovery & research and has strong pipeline of development products. In the financial services space, PEL has a real estate focused PE fund – Indiareit and a NBFC that is focused on lending to real estate and education sector. Recently, PEL has also entered the global information management industry through acquisition of a US based company - Decision Resources Group.